These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 160192)

  • 1. Sodium-independent, high-affinity binding of [3H]gamma-aminobutyric acid in human neurological disorders.
    Lloyd KG; Dreksler S; Shemen L; Davidson L
    Adv Exp Med Biol; 1979; 123():399-418. PubMed ID: 160192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of high affinity sodium-independent [3H]gamma-aminobutyric acid [3H]GABA binding in the human brain: alterations in Parkinson's disease.
    Iloyd KG; Shemen L; Hornykiewicz O
    Brain Res; 1977 May; 127(2):269-78. PubMed ID: 861759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [3H]GABA binding in brains from Huntington's chorea patients: altered regulation by phospholipids?
    Lloyd KG; Davidson L
    Science; 1979 Sep; 205(4411):1147-9. PubMed ID: 224459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D-1 and D-2 receptors in Huntington's disease.
    Cross A; Rossor M
    Eur J Pharmacol; 1983 Mar; 88(2-3):223-9. PubMed ID: 6221936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of [3H]gamma-aminobutyric acid (GABA) binding in the human brain.
    Lloyd KG; Dreksler S
    Brain Res; 1979 Mar; 163(1):77-87. PubMed ID: 218679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substantia nigra gamma-aminobutyric acid receptors in Huntington's disease.
    Cross AJ; Waddington JL
    J Neurochem; 1981 Aug; 37(2):321-4. PubMed ID: 6267198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzodiazepine receptors: the effect of GABA on their characteristics in human brain and their alteration in Huntington's disease.
    Reisine TD; Overstreet D; Gale K; Rossor M; Iversen L; Yamamura HI
    Brain Res; 1980 Oct; 199(1):79-88. PubMed ID: 6105905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoradiographic localization of gamma-aminobutyric acid receptors in the rat central nervous system by using [3H]muscimol.
    Chan-Palay V
    Proc Natl Acad Sci U S A; 1978 Feb; 75(2):1024-8. PubMed ID: 273213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases.
    Reynolds GP; Mason SL; Meldrum A; De Keczer S; Parnes H; Eglen RM; Wong EH
    Br J Pharmacol; 1995 Mar; 114(5):993-8. PubMed ID: 7780656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. gamma-Aminobutyric acid receptors in normal human brain and Huntington disease.
    Van Ness PC; Watkins AE; Bergman MO; Tourtellotte WW; Olsen RW
    Neurology; 1982 Jan; 32(1):63-8. PubMed ID: 6275305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of cannabinoid receptors in the substantia nigra in Huntington's disease.
    Glass M; Faull RL; Dragunow M
    Neuroscience; 1993 Oct; 56(3):523-7. PubMed ID: 8255419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imidazoline binding sites in Huntington's and Parkinson's disease putamen.
    Reynolds GP; Boulton RM; Pearson SJ; Hudson AL; Nutt DJ
    Eur J Pharmacol; 1996 Apr; 301(1-3):R19-21. PubMed ID: 8773473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycine receptors in the human substantia nigra as defined by [3H]strychnine binding.
    de Montis G; Beaumont K; Javoy-Agid F; Agid Y; Constandinidis J; Lowenthal A; Lloyd KG
    J Neurochem; 1982 Mar; 38(3):718-24. PubMed ID: 6276509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous inhibitors of Na+-independent [3H]GABA binding to crude synaptic membranes.
    Massotti M; Mazzari S; Schmid R; Guidotti A; Costa E
    Neurochem Res; 1981 May; 6(5):551-65. PubMed ID: 6269013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in 3H-GABA binding in Huntington's chorea.
    Lloyd KG; Dreksler S; Bird ED
    Life Sci; 1977 Sep; 21(5):747-53. PubMed ID: 198624
    [No Abstract]   [Full Text] [Related]  

  • 16. GABA receptor binding in the parkinsonian brain.
    Rinne UK; Koskinen V; Laaksonen H; Lönnberg P; Sonninen V
    Life Sci; 1978 Jun; 22(24):2225-8. PubMed ID: 672458
    [No Abstract]   [Full Text] [Related]  

  • 17. Kinetic and pharmacologic characterization of gamma-aminobutyric acid receptive sites from mammalian brain.
    Lester BR; Peck EJ
    Brain Res; 1979 Jan; 161(1):79-97. PubMed ID: 215278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal [3H]benzodiazepine binding and levels of GABA, glutamate, and taurine are normal in Huntington's disease cerebellum.
    Kish SJ; Shannak KS; Perry TL; Hornykiewicz O
    J Neurochem; 1983 Nov; 41(5):1495-7. PubMed ID: 6137518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of striatopallidal neurones utilizing gamma-aminobutyric acid in the pathophysiology of MPTP-induced parkinsonism in the primate: evidence from [3H]flunitrazepam autoradiography.
    Robertson RG; Clarke CA; Boyce S; Sambrook MA; Crossman AR
    Brain Res; 1990 Oct; 531(1-2):95-104. PubMed ID: 2289139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GABA receptor binding and endogenous inhibitors in normal human brain and Huntington's disease.
    Olsen RW; Van Ness P; Napias C; Bergman M; Tourtellotte WW
    Adv Biochem Psychopharmacol; 1980; 21():451-60. PubMed ID: 6246754
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.